Intravitreal Melphalan for Treatment of Primary Vitreoretinal Lymphoma: A New Indication for an Old Drug.

Authors

Carol L. Shields, Thomas Jefferson UniversityFollow
Kareem Sioufi, Thomas Jefferson University
Arman Mashayekhi, Thomas Jefferson UniversityFollow
Jerry A. Shields, Thomas Jefferson UniversityFollow

Document Type

Article

Publication Date

7-1-2017

Comments

This article has been peer reviewed. It is the author’s final published version in JAMA Ophthalmology

Volume 135, Issue 7, July 2017, Pages 815-818.

The published version is available at DOI: 10.1001/jamaophthalmol.2017.1810. Copyright © American Medical Association

Recommended Citation

Shields, Carol L.; Sioufi, Kareem; Mashayekhi, Arman; and Shields, Jerry A., "Intravitreal Melphalan for Treatment of Primary Vitreoretinal Lymphoma: A New Indication for an Old Drug." (2017). Wills Eye Hospital Papers. Paper 69.
https://jdc.jefferson.edu/willsfp/69

PubMed ID

28617918